Cancer Genetics has appointed Michael McCartney as chief commercial officer, effective immediately. McCartney was previously CEO of SciKon Innovation, an early-stage life science company. Before that, he was SciKon's COO. He has more than 20 years of experience in the life science space including positions at Roche, Siemens, and Abbott.
Rohan Hastie, John Ryals